JAMA Neurology

Association between Increased Seizures during Rewarming after Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up: A Nested Multisite Cohort Study.  78:1484-1493. 2021

Association between Intracerebral Hemorrhage and Subsequent Arterial Ischemic Events in Participants from 4 Population-Based Cohort Studies.  78:809-816. 2021

Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients with Painful Diabetic Neuropathy: A Randomized Clinical Trial.  78:687-698. 2021

Outcomes and Risk Factors Associated with SARS-CoV-2 Infection in a North American Registry of Patients with Multiple Sclerosis.  78:699-708. 2021

Sex Disparities in Enrollment in Recent Randomized Clinical Trials of Acute Stroke: A Meta-analysis.  78:666-677. 2021

Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.  78:536-547. 2021

Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial.  78:285-292. 2021

Association of Initial β-Amyloid Levels with Subsequent Flortaucipir Positron Emission Tomography Changes in Persons without Cognitive Impairment.  78:217-228. 2021

Burden of Neurological Disorders across the US from 1990-2017: A Global Burden of Disease Study.  78:165-176. 2021

Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.  78:30-40. 2021

Seven-Year Experience from the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.  77:755-763. 2020

Association of Black Race with Early Recurrence after Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial.  77:601-605. 2020

Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients with Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.  77:215-224. 2020

Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients with Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study.  76:1147-1156. 2019

Inclusivity of Diverse Patient Groups - Reply.  76:984-985. 2019

Sex and Race Differences in the Association of Incident Ischemic Stroke with Risk Factors.  76:179-186. 2019

The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We out of the Haze?.  76:135-136. 2019

Participation in Get with the Guidelines-Stroke and Its Association with Quality of Care for Stroke.  75:1331-1346. 2018

Sex-specific association of apolipoprotein e with cerebrospinal fluid levels of tau.  75:989-998. 2018

Association of sickle cell trait with ischemic stroke among African americans a meta-analysis.  75:802-807. 2018

Efficacy and safety of deep brain stimulation in tourette syndrome the international tourette syndrome deep brain stimulation public database and registry.  75:353-359. 2018

Bioequivalence between generic and branded lamotrigine in people with epilepsy: The EQUIGEN randomized clinical trial.  74:919-926. 2017

Safety of converting from tetrabenazine to deutetrabenazine for the treatment of Chorea.  74:977-982. 2017

Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease.  74:557-566. 2017

Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy..  73:1070-1077. 2016

Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults.  73:721-732. 2016

Autism screening or smoke screen and mirrors?.  73:386-387. 2016

The case for neurological network diseases.  73:261-262. 2016

Clinical-genetic associations in the Prospective Huntington at Risk Observational Study (PHAROS) implications for clinical trials.  73:102-110. 2016

Whole-exome sequencing in familial Parkinson disease.  73:68-75. 2016

Association of long runs of homozygosity with Alzheimer disease among African American individuals.  72:1313-1323. 2015

Indirect measures of arterial stiffness and cognitive performance in individuals without traditional vascular risk factors or disease.  72:309-315. 2015

Rarity of the alzheimer disease-protective APP A673T variant in the United States.  72:209-216. 2015

Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: A genome-wide association study.  71:1394-1404. 2014

The future of neuroscience clinical trials-reply..  71:652-653. 2014

A randomized clinical trial of high-dosage coenzyme Q10 in early parkinson disease no evidence of benefit.  75:543-552. 2014

Cognitive and motor function in long-duration PARKIN-associated parkinson disease.  71:62-67. 2014

Does natalizumab therapy benefit patients with multiple sclerosis?.  71:945-946. 2014

In reply.  71:652-653. 2014

Network for excellence in neuroscience clinical trials NeuroNEXT.  70:1227-1228. 2013